X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · IEX Real-Time Price · USD
0.759
+0.011 (1.47%)
At close: Jul 19, 2024, 4:00 PM
0.720
-0.039 (-5.14%)
Pre-market: Jul 22, 2024, 7:33 AM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $127.46 million as of July 22, 2024. Its market cap has decreased by -43.62% in one year.
Market Cap
127.46M
Enterprise Value
104.87M
1-Year Change
-43.62%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since November 16, 2017, X4 Pharmaceuticals's market cap has decreased from $192.10M to $127.46M, a decrease of -33.65%. That is a compound annual growth rate of -5.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 127.50M | -9.19% |
| Dec 29, 2023 | 140.40M | 104.07% |
| Dec 30, 2022 | 68.80M | 21.55% |
| Dec 31, 2021 | 56.60M | -45.94% |
| Dec 31, 2020 | 104.70M | -21.46% |
| Dec 31, 2019 | 133.30M | 301.51% |
| Dec 31, 2018 | 33.20M | -81.00% |
| Dec 29, 2017 | 174.70M | -9.06% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DIH Holdings US | 133.80M |
| Harvard Bioscience | 133.76M |
| Tevogen Bio Holdings | 133.36M |
| Veru Inc. | 132.29M |
| Compass Therapeutics | 128.89M |
| Immunic | 127.01M |
| Annovis Bio | 126.57M |
| Agenus | 125.79M |